UC Davis researchers find low-fat diets slowed pancreatic precancer development in mice, even after weight gain.

Vincent Picozzi, MD, discusses findings from the phase 3 trial PANOVA-3 of TTFields with gemcitabine and nab-paclitaxel in locally advanced pancreatic cancer.

The team has been awarded a $2.5 million grant to develop a system for inserting tiny light-emitting fibers directly into ...

A protein called PCSK9 determines how pancreatic cancer cells metastasize to different parts of the body.

Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs or liver, environments that ...

Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...

Novocure (Nasdaq:NVCR) today announced positive results from the Phase 3 PANOVA-3 trial of its tumor-treating fields ...

Annual Meeting, multiple companies presented clinical trial data showing their drugs and devices helped patients with pancreatic cancer live longer or improve their ability to respond to treatment.

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...

Our analysis of ecdysone-induced downstream targets reveals that overexpression of the nuclear receptor E75, particularly facilitates the malignant transformation of benign tumors. Genome-wide DNA ...

Liver biopsy specimen was demonstrated grade 2 neuroendocrine tumor compatible with clinical and radiological results. He was followed under the treatment of continuous intravenous glucose infusion ...